Member news

Eurofins revenues grow 27% in Q1 2019 to EUR 1,067m

More at eurofins.com…

MorphoSys and Galapagos Announce Initiation of GECKO Phase 2 Study with MOR106 in Atopic Dermatitis Patients

More at morphosys.com…

4SC provides Q1 2019 update

More at 4sc.com…

Pieris Pharmaceuticals Presents Preclinical Data for GPC3/4-1BB Bispecific PRS-342 at the 2019 American Association for Cancer Research (AACR) Annual Meeting

More at ir.pieris.com…

Medigene presented selective killing of tumor cells by PRAME TCR-transduced T cells at AACR

More at medigene.com…

Dr. Sarah Fakih joins MorphoSys as Head of Corporate Communications and Investor Relations

More at morphosys.com…

NOXXON presents updated results from Phase 1/2 NOX-A12 / Keytruda combination trial at AACR 2019

More at noxxon.com…

Dynavax’s SD-101 and 4SC’s Domatinostat Demonstrate Synergy and Induce a Systemic Anti-tumor Response in Preclinical Models

More at 4sc.com…

InflaRx Full Year 2018 Financial & Operating Results

More at inflarx.de…